Delivery Order SPE2DB20D1100-SPE2DB25FE1W8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,601.43 for Forteo (560 mcg/2.24 mL pen injection), a pharmaceutical product used in osteoporosis treatment. This firm fixed-price delivery order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was competitively procured with no...
- The Defense Logistics Agency awarded a $7,804.29 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This contract represents a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. As a leading pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,087.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) under a firm fixed-price contract. This non-set-aside award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a single delivery transaction for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) with a ceiling value of $16,198.68. This firm fixed-price delivery order, which is due for completion by August 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award utilized no set-aside designation and was competitively awarded. The pharmaceutical...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 1, 2025. This non-set-aside contract represents a single delivery order fulfillment of this pharmaceutical product, which is commonly used for osteoporosis treatment. The award was made to AmerisourceBergen's Corporate Office division, based in Conshohocken, Pennsylvania, where the place of...
- The Defense Logistics Agency awarded a delivery order valued at $62,529.46 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $17,249.94 delivery order to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 ml pen injections with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $20,336.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections), a pharmaceutical product used to treat osteoporosis. The contract was competitively awarded without set-aside designation and has an ultimate completion date of July 22, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,054.76 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1W8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) valued at $2,601.43. This non-set-aside, firm fixed-price delivery order was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical supply vehicle running through December 2026 that authorizes the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies medications across multiple therapeutic domains to defense and civilian healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company holds a significant competitive position in federal pharmaceutical procurement, consistently winning non-set-aside delivery orders through open competition. This specific order for Forteo, a brand-name osteoporosis treatment, represents a routine fulfillment under the company's expansive prime vendor contract that enables flexible procurement of specialty medications, brand-name and generic drugs, and related medical supplies for military health services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/20/25 |